Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

Is erectile dysfunction a sign of prostate cancer? This is a common concern for many men experiencing erectile difficulties. Whilst both conditions are prevalent in older men in the UK, erectile dysfunction (ED) is not typically a direct sign of prostate cancer itself. Early-stage prostate cancer rarely causes erectile problems, as the disease usually develops slowly without immediately affecting the nerves and blood vessels responsible for erections. The more significant connection relates to cancer treatment rather than the disease. Understanding this relationship helps men determine when medical evaluation is necessary and empowers informed health decisions.
Summary: Erectile dysfunction is not typically a direct sign of prostate cancer, as early-stage disease rarely causes erectile problems; the connection relates primarily to cancer treatment rather than the disease itself.
Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It is common in the UK, affecting approximately 40% of men by age 40, with prevalence increasing significantly with age. ED is not a disease in itself but rather a symptom that can arise from various physical, psychological, or lifestyle factors.
Prostate cancer is the most common cancer in men in the UK, with around 52,000 new cases diagnosed annually. The prostate gland sits below the bladder and surrounds the urethra, playing a crucial role in male reproductive function by producing seminal fluid. When cancer develops in the prostate, it often grows slowly, though some types can be aggressive, and early-stage disease may not cause symptoms for many years.
Whilst both conditions are common in older men, it is important to understand that they are distinct medical issues with different underlying causes. The prostate gland and the mechanisms responsible for erectile function are anatomically related, which can lead to confusion about whether one condition directly causes the other. The nerves and blood vessels that control erections run very close to the prostate, which explains why prostate problems—including cancer and its treatment—can sometimes affect erectile function.
Understanding the relationship between these two conditions is essential for men experiencing erectile difficulties, as it helps determine when medical evaluation is necessary and what investigations might be appropriate. This knowledge empowers patients to make informed decisions about their health and seek timely medical advice when needed.
Erectile dysfunction is not typically a direct sign of prostate cancer itself. In the early stages, prostate cancer rarely causes erectile problems, as the disease usually develops slowly and does not immediately affect the nerves and blood vessels responsible for erections. Most men with early-stage prostate cancer experience no symptoms at all.
ED alone is not an indication for urgent referral or PSA testing under NICE guidelines (NG12). When prostate cancer does cause erectile difficulties, this typically occurs only in advanced disease where the tumour has grown large enough to affect surrounding structures, including the neurovascular bundles that control erectile function. However, advanced disease may present with other symptoms such as bone pain, weight loss, or neurological symptoms, not only urinary symptoms.
The more significant connection between ED and prostate cancer relates to cancer treatment rather than the disease itself. Treatments for prostate cancer—including radical prostatectomy (surgical removal of the prostate), radiotherapy, and hormone therapy—can all cause erectile dysfunction as a side effect. Surgery and radiotherapy may damage the delicate nerves and blood vessels near the prostate, whilst hormone therapy (androgen deprivation therapy) reduces testosterone levels, which are essential for normal erectile function.
It is worth noting that ED and prostate cancer share common risk factors, including advancing age, family history, Black African or Caribbean ethnicity, and certain health conditions. Obesity is more strongly associated with aggressive prostate cancer. This means that men with erectile dysfunction may have an increased likelihood of developing prostate cancer due to shared risk factors, rather than one causing the other. If you are experiencing erectile difficulties, this should prompt a comprehensive health assessment rather than immediate concern about prostate cancer specifically.
Erectile dysfunction has numerous potential causes, which can be broadly categorised into physical, psychological, and lifestyle factors. Understanding these helps contextualise why ED alone is not indicative of prostate cancer.
Cardiovascular disease is one of the most common physical causes of ED. Erections require adequate blood flow to the penis, and conditions such as atherosclerosis (narrowing of blood vessels), hypertension, and high cholesterol can impair this process. ED can serve as an early warning sign of cardiovascular disease, which is why NICE guidance recommends cardiovascular risk assessment (QRISK) for men with erectile problems. Diabetes is another major cause, affecting both blood vessels and nerves that control erectile function—approximately 50% of men with diabetes experience some degree of ED.
Neurological conditions including multiple sclerosis, Parkinson's disease, stroke, and spinal cord injuries can disrupt the nerve signals necessary for erections. Hormonal imbalances, particularly low testosterone (hypogonadism), can reduce libido and erectile function. Certain medications can cause ED as a side effect, including some antihypertensives (particularly beta-blockers and thiazide diuretics), antidepressants (especially SSRIs), and antipsychotics. If you suspect medication may be contributing to ED, discuss this with your GP rather than stopping prescribed medicines without medical advice.
Psychological factors play a significant role in many cases of ED. Stress, anxiety, depression, and relationship difficulties can all interfere with sexual function. Performance anxiety can create a self-perpetuating cycle where worry about erectile failure actually contributes to the problem. Lifestyle factors including excessive alcohol consumption, smoking, recreational drug use, obesity, and lack of physical activity are all associated with increased ED risk.
Pelvic surgery or trauma, including procedures on the prostate, bladder, or rectum, can damage the nerves and blood vessels involved in erectile function. Peyronie's disease, characterised by scar tissue in the penis causing curvature, can also contribute to erectile difficulties.
You should consult your GP if erectile difficulties persist for more than a few weeks or are causing distress or relationship problems. Whilst occasional erectile problems are common and not usually cause for concern, persistent ED warrants medical evaluation as it may indicate underlying health conditions requiring treatment.
Seek medical advice promptly if:
Erectile dysfunction develops suddenly rather than gradually
You experience ED alongside chest pain, shortness of breath, or other cardiovascular symptoms
You have additional symptoms such as difficulty urinating, blood in urine, pelvic pain, or unexplained weight loss
You notice reduced libido, fatigue, or other symptoms that might suggest hormonal imbalances
ED is affecting your mental health, causing anxiety, depression, or relationship difficulties
You are taking new medications and suspect they may be contributing to erectile problems
Your GP will typically conduct a comprehensive assessment including a detailed medical and sexual history, review of current medications, and examination of cardiovascular risk factors. They may perform a physical examination, including assessment of secondary sexual characteristics, blood pressure measurement, BMI calculation, and examination of the genitals and prostate if indicated.
Investigations may include blood tests to check for diabetes (HbA1c or fasting glucose), lipid profile, testosterone levels (measured in the morning when levels are highest, with repeat testing if low), and thyroid function. If hypogonadism is suspected, additional tests such as luteinising hormone (LH), follicle-stimulating hormone (FSH), and prolactin may be considered. A cardiovascular risk assessment (QRISK) is also recommended.
Your GP can discuss treatment options, which may include lifestyle modifications, addressing underlying health conditions, changing medications if appropriate, or prescribing phosphodiesterase-5 (PDE5) inhibitors such as sildenafil, tadalafil, vardenafil, or avanafil. These medications are contraindicated in men taking nitrates and require caution with alpha-blockers; a cardiovascular assessment is necessary before prescribing. Referral to specialist services may be arranged if first-line treatments are unsuccessful or if there are concerns about underlying conditions requiring specialist investigation, such as penile deformity (urology), endocrine abnormalities (endocrinology), or suspected cancer (two-week wait referral).
If you experience side effects from any medication, report them to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).
Early-stage prostate cancer typically causes no symptoms. In the UK, there is no national screening programme for prostate cancer, though men aged 50 and over (or from age 45 if at higher risk) can request a PSA test after an informed discussion with their GP about the potential benefits and limitations, as part of the Prostate Cancer Risk Management Programme (PCRMP).
Urinary symptoms are the most common presenting features when prostate cancer does cause symptoms. These may include:
Increased urinary frequency, particularly at night (nocturia)
Urgency or difficulty starting urination
Weak or interrupted urine flow
Sensation of incomplete bladder emptying
Blood in the urine (haematuria)
It is crucial to understand that these lower urinary tract symptoms (LUTS) are far more commonly caused by benign prostatic hyperplasia (BPH)—non-cancerous enlargement of the prostate—than by cancer. BPH affects approximately 50% of men over 50 and 80% of men over 80.
Advanced prostate cancer may cause additional symptoms including:
Bone pain, particularly in the back, hips, or pelvis (indicating possible bone metastases)
Unexplained weight loss
Erectile dysfunction (though as discussed, this is not typically an early sign)
Blood in semen (haematospermia)
Leg swelling or weakness (if cancer affects lymph nodes or spinal cord)
NICE guidance (NG12) recommends considering a PSA test and digital rectal examination (DRE) for men with lower urinary tract symptoms. An urgent two-week wait referral to a specialist should be made if there is an abnormal DRE (suggesting prostate cancer) or a raised PSA above the age-specific reference range. Men should be informed about the limitations and implications of PSA testing, including the possibility of false positives and the potential for detecting slow-growing cancers that may never cause problems.
When to seek urgent medical advice:
Blood in urine
Severe bone pain
Sudden inability to urinate (urinary retention)
Unexplained weight loss with urinary symptoms
New back pain with leg weakness or numbness
Blood in semen (haematospermia) should prompt a GP visit but is rarely due to cancer and usually isn't an urgent presentation unless persistent or accompanied by other symptoms.
If you are concerned about prostate cancer risk, discuss testing options with your GP, particularly if you are over 50, of Black African or Caribbean ethnicity, or have a family history of prostate cancer, as these factors increase risk. Remember that most men with urinary symptoms do not have cancer, but medical evaluation is important to determine the cause and appropriate management.
Early-stage prostate cancer rarely causes erectile dysfunction directly. ED typically occurs only with advanced disease or, more commonly, as a side effect of prostate cancer treatments such as surgery, radiotherapy, or hormone therapy.
Erectile dysfunction alone is not an indication for urgent PSA testing under NICE guidelines. However, persistent ED warrants a comprehensive GP assessment to identify underlying causes such as cardiovascular disease or diabetes, which are more common causes than prostate cancer.
Early prostate cancer typically causes no symptoms. When symptoms do occur, they include urinary changes (frequency, urgency, weak flow), blood in urine, and in advanced disease, bone pain or unexplained weight loss. These symptoms warrant GP evaluation and possible PSA testing.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript